The chemists of the “Metal complexes and MRI” research group have developed novel imaging probes which specifically recognise amyloid aggregates, characteristic of Alzheimer’s Disease and Diabetes and gained new insights into their peptide binding mechanisms. These results could facilitate early diagnosis and better molecular understanding of these diseases.
A lire aussi
11 juillet 2025 : séminaire de Timothy Reichart
02 July 2025
par Isabelle Frapart
2025, July 11 - Timothy Reichart seminar
02 July 2025
par Isabelle Frapart
2025, July 4: Malika Mekhalfi seminar
01 July 2025
par Isabelle Frapart